HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TLR-7 activation enhances IL-22-mediated colonization resistance against vancomycin-resistant enterococcus.

Abstract
Antibiotic administration can disrupt the intestinal microbiota and down-regulate innate immune defenses, compromising colonization resistance against orally acquired bacterial pathogens. Vancomycin-resistant Enterococcus faecium (VRE), a major cause of antibiotic-resistant infections in hospitalized patients, thrives in the intestine when colonization resistance is compromised, achieving extremely high densities that can lead to bloodstream invasion and sepsis. Viral infections, by mechanisms that remain incompletely defined, can stimulate resistance against invading bacterial pathogens. We report that murine norovirus infection correlates with reduced density of VRE in the intestinal tract of mice with antibiotic-induced loss of colonization resistance. Resiquimod (R848), a synthetic ligand for Toll-like receptor 7 (TLR-7) that stimulates antiviral innate immune defenses, restores expression of the antimicrobial peptide Reg3γ and reestablishes colonization resistance against VRE in antibiotic-treated mice. Orally administered R848 triggers TLR-7 on CD11c(+) dendritic cells, inducing interleukin-23 (IL-23) expression followed by a burst of IL-22 secretion by innate lymphoid cells, leading to Reg3γ expression and restoration of colonization resistance against VRE. Our findings reveal that an orally bioavailable TLR-7 ligand that stimulates innate antiviral immune pathways in the intestine restores colonization resistance against a highly antibiotic-resistant bacterial pathogen.
AuthorsMichael C Abt, Charlie G Buffie, Bože Sušac, Simone Becattini, Rebecca A Carter, Ingrid Leiner, James W Keith, David Artis, Lisa C Osborne, Eric G Pamer
JournalScience translational medicine (Sci Transl Med) Vol. 8 Issue 327 Pg. 327ra25 (Feb 24 2016) ISSN: 1946-6242 [Electronic] United States
PMID26912904 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2016, American Association for the Advancement of Science.
Chemical References
  • CD11c Antigen
  • Imidazoles
  • Interferon Type I
  • Interleukin-1
  • Interleukin-23
  • Interleukins
  • Ligands
  • Pancreatitis-Associated Proteins
  • Proteins
  • Reg3g protein, mouse
  • Toll-Like Receptor 7
  • Vancomycin
  • Ampicillin
  • resiquimod
Topics
  • Ampicillin (pharmacology)
  • Animals
  • CD11c Antigen (metabolism)
  • Caliciviridae Infections (complications, pathology, virology)
  • Colony Count, Microbial
  • Dendritic Cells (drug effects, metabolism)
  • Drug Resistance, Bacterial (drug effects)
  • Enterococcus (drug effects, growth & development)
  • Gastroenteritis (complications, pathology, virology)
  • Imidazoles (pharmacology)
  • Interferon Type I (metabolism)
  • Interleukin-1 (metabolism)
  • Interleukin-23 (metabolism)
  • Interleukins (metabolism)
  • Ligands
  • Mice, Inbred C57BL
  • Norovirus (drug effects, physiology)
  • Pancreatitis-Associated Proteins
  • Proteins (metabolism)
  • Signal Transduction (drug effects)
  • Toll-Like Receptor 7 (metabolism)
  • Vancomycin (pharmacology)
  • Interleukin-22

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: